Page 0059

INCTR UPDATE

59 CANCER CONTROL 2021

Individuals, institutions or organizations often choose to serve

as Associate Members who contribute financially to the work of

INCTR.

What does INCTR do?

INCTR addresses all aspects of cancer control with the overall

goal of lessening the morbidity and mortality from cancer. It

emphasizes training and education of healthcare professionals

in LMICs to ensure that "best practices" are instilled in cancer

prevention, early diagnosis, treatment and palliative care.

Research is an integral part of its work with its partners in LMICs

in order to accurately document the cancer burden - including the

types of cancer and extent of disease, the outcomes of prevention

and early detection campaigns and the efficacy, toxicity and cost

of treatment delivered. It also emphasizes public awareness

of cancer, which is an essential component of early diagnosis.

INCTR has a variety of programmes that are carried out in close

collaboration with its branches as well as its partner institutions in

developing countries. INCTR's current programmes include:

J adult oncology; J cancer registry;

J clinical research; J foundational;

J palliative care; J paediatric oncology;

J pathology.

INCTR's projects and achievements

Each INCTR programme has goals and objectives in line with the

overall mission of the organization, divided into separate projects.

Many projects have been conducted or are on-going and include:

Adult oncology

J Prevention, early diagnosis, and treatment of selected cancers

in poor urban areas and in rural and tribal regions in the state

of Rajasthan in India.

J Cervical cancer screening using visual inspection in Nepal and

Tanzania.

J Training of Bolivian healthcare professionals in cervical cancer

screening by Peruvian experts.

J HPV vaccination of young girls in Nepal.

Cancer registries

J Establishing an East African Registry Network (EARN) that

0 5 10 15 20 25 30 35 40 45

30

25

20

15

10

5

0

% of global workforce

Size of the dots is proportional to total health expenditure% of global burden of disease

Western Pacific

Europe

Americas

Africa

South-East Asia

Eastern Mediterranean

(Source: WHO, 2006)

Distribution of health workers by level of health expenditure

and burden of disease, WHO regions

66

8000000

) (16.4.2012)

4161941

) (16.4.2012)

000 4500000 5000000

nternet].

an.iarc.fr Accessed: 8 March 2013.

den of cancer in 2008:

80(9856):1840-50.

2008 total incident cases 7.1 million

2030 total incident cases 12.7 million

World

All cancers excl. non-melanoma skin cancer

Number of new cancers in 2030 (all ages)

World

All cancers excl. non-melanoma skin cancer

Number of new cancers in 2030 (all ages) - Both sexes

Male

Female

11471506

9790012

0 2000000 4000000 6000000 8000000 10000000 12000000 14000000

(Source: GLOBOCAN 2008 (IARC) (19.3.2013)

21261518

(Source: GLOBOCAN 2008 (IARC) (19.3.2013)

0 5000000 10000000 15000000 20000000 25000000

■ Incidence in 2008 ■ Demographic effect

■ Incidence in 2008 ■ Demographic effect

Adapted with permission from:

Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM.

GLOBOCAN 2008 v2.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet].

Lyon, France: International Agency for Research on Cancer; 2010. Available from: http://globocan.iarc.fr Accessed: 8 March 2013.

Soerjomataram I, Lortet-Tieulent J, Parkin DM, Ferlay J, Mathers C, Forman D, Bray F. Global burden of cancer in 2008:

a systematic analysis of disability-adjusted life-years in 12 world regions. Lancet. 2012 Nov 24;380(9856):1840-50.

Figure 1: Disease burden and resources

STRATEGIES

J To build capacity for cancer prevention, diagnosis, treatment

and palliation through professional education and training

J To conduct, or provide materials for the conduct of educational

campaigns for the public and primary care doctors about the

causes of cancer and living a healthier life

J To work with experts in-country to conduct locally relevant

research on cancer control

2008 total incident cases 7.1 million

2030 total incident cases 12.7 million

Less developed regions

All cancers excl. non-melanoma skin cancer

Number of new cancers in 2030 (all ages)

2008 total incident cases 2.3 million

2030 total incident cases 7.4 million

0 5 10 15 20 25 30 35 40 45

30

25

20

15

10

5

0

% of global workforce

Size of the dots is proportional to total health expenditure% of global burden of disease

Western Pacific

Europe

Americas

Africa

South-East Asia

Eastern Mediterranean

(Source: WHO, 2006)

Distribution of health workers by level of health expenditure

and burden of disease, WHO regions

More developed regions

All cancers excl. non-melanoma skin cancer

Number of new cancers in 2030 (all ages)

Male

Female

6733466

6053193

0 1000000 2000000 3000000 4000000 5000000 6000000 7000000 8000000

(Source: GLOBOCAN 2008 (IARC) (16.4.2012)

Male

Female

4161941

3263670

(Source: GLOBOCAN 2008 (IARC) (16.4.2012)

0 500000 1000000 1500000 2000000 2500000 3000000 3500000 4000000 4500000 5000000

■ Incidence in 2008 ■ Demographic effect

■ Incidence in 2008 ■ Demographic effect

Founder and

active members

Associate members

Advisory Board

Branches

Programmes

Clinical research

Pathology

Paediatric oncology

Cancer registry

Oncology nursing

Foundational

Palliative care

Governing Council

Executive Committee

Committees

Ethical

review

OERC

consortium Funding

Disease-specific

startegy groups Adapted with permission from:

Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM.

GLOBOCAN 2008 v2.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet].

Lyon, France: International Agency for Research on Cancer; 2010. Available from: http://globocan.iarc.fr Accessed: 8 March 2013.

Soerjomataram I, Lortet-Tieulent J, Parkin DM, Ferlay J, Mathers C, Forman D, Bray F. Global burden of cancer in 2008:

a systematic analysis of disability-adjusted life-years in 12 world regions. Lancet. 2012 Nov 24;380(9856):1840-50.

2008 total incident cases 7.1 million

2030 total incident cases 12.7 million

World

All cancers excl. non-melanoma skin cancer

Number of new cancers in 2030 (all ages)

World

All cancers excl. non-melanoma skin cancer

Number of new cancers in 2030 (all ages) - Both sexes

Male

Female

11471506

9790012

0 2000000 4000000 6000000 8000000 10000000 12000000 14000000

(Source: GLOBOCAN 2008 (IARC) (19.3

21261518

(Source: GLOBOCAN 2008 (IARC) (19.3

0 5000000 10000000 15000000 20000000 250000

■ Incidence in 2008 ■ Demographic effect

■ Incidence in 2008 ■ Demographic effect

Adapted with permission from:

Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM.

GLOBOCAN 2008 v2.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]

Lyon, France: International Agency for Research on Cancer; 2010. Available from: http://globocan.iarc.fr

Soerjomataram I, Lortet-Tieulent J, Parkin DM, Ferlay J, Mathers C, Forman D, Bray F. Global burden of c

a systematic analysis of disability-adjusted life-years in 12 world regions. Lancet. 2012 Nov 24;380(985

Figure 2: Disease burden and resources

to become familiar with the most pressing issues and to develop

plans to improve efficiency and reduce cost. Although clearly

many countries have limited health workforces and quantitation

of such workforces can be valuable in terms of planning for the

future, it realizes that many cancer plans have little impact

because of the limited resources and great difficulty in expanding

interventions to very poor populations which cannot "purchase"

their own healthcare needs and which have little or no chance of

expanding their present resources. Having a cancer plan is not

enough. Successful cancer plans require knowledge and a budget

in addition to educated health professionals.

INCTR's structure

INCTR has consultants and volunteers dedicated to the

accomplishment of its goals. Although its headquarters are

located in Brussels, it has branches in the United States, Canada,

Brazil, United Kingdom, France, Egypt, Nepal and India. Branches

are legally-established NGOs that contribute to and conduct

programmes and projects that are relevant to INCTR's mission.

Resource development, administration and programmes (e.g.,

adult oncology, paediatric oncology, cancer registries, pathology

and palliative care are supervised by an Executive Committee or

directly by the branches. The Executive Committee is responsible

to INCTR's Governing Council. Programmes and projects are

developed with the participation, input and advice of various

INCTR committees and strategy groups, as well as independent

scientific advisers. Programmes and projects are conducted

in collaboration with partner institutions involved with cancer

research, diagnosis and treatment, including palliative care and

education in countries with limited resources.

Index

  1. Page 0001
  2. Page 0002
  3. Page 0003
  4. Page 0004
  5. Page 0005
  6. Page 0006
  7. Page 0007
  8. Page 0008
  9. Page 0009
  10. Page 0010
  11. Page 0011
  12. Page 0012
  13. Page 0013
  14. Page 0014
  15. Page 0015
  16. Page 0016
  17. Page 0017
  18. Page 0018
  19. Page 0019
  20. Page 0020
  21. Page 0021
  22. Page 0022
  23. Page 0023
  24. Page 0024
  25. Page 0025
  26. Page 0026
  27. Page 0027
  28. Page 0028
  29. Page 0029
  30. Page 0030
  31. Page 0031
  32. Page 0032
  33. Page 0033
  34. Page 0034
  35. Page 0035
  36. Page 0036
  37. Page 0037
  38. Page 0038
  39. Page 0039
  40. Page 0040
  41. Page 0041
  42. Page 0042
  43. Page 0043
  44. Page 0044
  45. Page 0045
  46. Page 0046
  47. Page 0047
  48. Page 0048
  49. Page 0049
  50. Page 0050
  51. Page 0051
  52. Page 0052
  53. Page 0053
  54. Page 0054
  55. Page 0055
  56. Page 0056
  57. Page 0057
  58. Page 0058
  59. Page 0059
  60. Page 0060
  61. Page 0061
  62. Page 0062
  63. Page 0063
  64. Page 0064
  65. Page 0065
  66. Page 0066